Pamiscell is trading at 22,450 KRW as of 10:38 AM on the 10th, up 2.75% from the previous day. This represents a 10.86% increase compared to May 15. Pamiscell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

Today, foreigners are tentatively recorded as net buyers of 64,000 shares. Over the past five days, individual investors have been net sellers of 53,930 shares, while foreigners and institutions have been net buyers of 58,523 shares and 12,340 shares, respectively.



[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing